Dow Jones

40 211,72

0,00%

DAX

Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
NASDAQ
Allos Therapeutics, Inc. (MM) (ALTH)
Allos Therapeutics, Inc. (MM) (ALTH) Actualités

ALTH

Allos Therapeutics, Inc. (MM) (ALTH)

Allos Therapeutics, Inc. (MM)

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:NASDAQ:ALTH

<< Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
03/02/2010	14h00	Business Wire	Allos Therapeutics to Present at BIO CEO & Investor Conference	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
29/01/2010	22h09	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
19/01/2010	21h53	Edgar (US Regulatory)	Statement of Ownership (SC 13G)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
13/01/2010	01h04	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
06/01/2010	14h00	Business Wire	Allos Therapeutics to Present at J.P. Morgan Healthcare Conference	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
11/12/2009	12h25	Marketwired	Wall St Sense Offers In-depth Research on the Services, Financial and Healthcare Sectors' Key Players	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
08/12/2009	15h15	Business Wire	Allos Therapeutics’ FOLOTYN™ Shows Activity in a Dose Finding Phase 1 Study of Relapsed or Refractory Cutaneous T-Cell Ly...	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
07/12/2009	19h22	Dow Jones News	2nd UPDATE: Celgene To Buy Gloucester Pharma for At Least $340 Million	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
07/12/2009	16h00	Business Wire	Allos Therapeutics’ FOLOTYN™ Demonstrates Activity in Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma Tre...	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
05/12/2009	16h00	Business Wire	Allos Therapeutics Reports New Analyses of Data from Pivotal PROPEL Trial of FOLOTYN™ at 51st ASH Annual Meeting	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
04/12/2009	14h00	Business Wire	Allos Therapeutics Announces an Agreement with Idis for a Named Patient Program for FOLOTYN™ (pralatrexate injection)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
03/12/2009	14h00	Business Wire	Allos Therapeutics to Launch Global Registry for Patients with Peripheral T-Cell Lymphoma at the American Society of Hematolo...	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
30/11/2009	14h00	Business Wire	Allos Therapeutics Announces Issuance of U.S. Patent for FOLOTYN	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
23/11/2009	12h38	Marketwired	Ridgewater Equity Reviews the Following Equities Human Genome Sciences Inc., Intuit Inc., Advanced Battery Technologies, Linn En	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
11/11/2009	14h00	Business Wire	Allos Therapeutics Announces New Data on FOLOTYN™ to be Presented at the American Society of Hematology Meeting	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
11/11/2009	12h54	Marketwired	AnalystChoice.com Provides Analytical Coverage on ELNK, NWSA, NTAP, ALTH, HANS and BPOP	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
10/11/2009	15h51	Business Wire	Allos Therapeutics to Present at Upcoming Conferences in November	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
03/11/2009	22h11	Edgar (US Regulatory)	Quarterly Report (10-Q)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
03/11/2009	22h01	Business Wire	Allos Therapeutics Reports Third Quarter 2009 Financial Results	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
02/11/2009	11h12	Marketwired	Global Market Perspective Review on ALTH, CINF, ALKS, DBRN, APOL and INFY from TheFortuneFinancial.com	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
26/10/2009	13h00	Business Wire	Allos Therapeutics to Report Third Quarter 2009 Results on November 3, 2009	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
22/10/2009	12h57	Marketwired	BenchmarkJournal.com Provides Sector & Company Analysis on OMC, PSE, PWR, ALTH, NWSA and ELNK	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
13/10/2009	22h05	Business Wire	Allos Therapeutics Announces Closing of Public Offering	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
13/10/2009	12h40	Marketwired	ELNK, HERO, ABAT, NTAP, DBRN and ALTH Receives Analytical Coverage from WallStSense.com	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
07/10/2009	23h08	Edgar (US Regulatory)	Prospectus filed pursuant to Rule 424(b)(5) (424B5)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
07/10/2009	12h19	Edgar (US Regulatory)	Free Writing Prospectus - Filing under Securities Act Rules 163/433 (FWP)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
07/10/2009	12h14	Business Wire	Allos Therapeutics Announces Pricing of Public Offering of Common Stock	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
05/10/2009	22h01	Business Wire	Allos Therapeutics Announces Proposed Public Offering of Common Stock	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
05/10/2009	13h00	Business Wire	Allos Therapeutics Announces U.S. Availability of FOLOTYN™ (pralatrexate injection) for Relapsed or Refractory Peripheral T...	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
01/10/2009	12h36	Marketwired	RothmanResearch.com Stock Review for SCG, CA, NE, MKC, COL and ALTH	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)